Pharmacological activities of TEI-8362, a novel inhibitor of human neutrophil elastase

British Journal of Pharmacology

Volumn 126, Issue 5, 1999, Pages 1147-1152

  Mitsuhashi, Hiroaki ^a   Nonaka, Takashi ^a   Hamamura, Ichiro ^a   Kishimoto, Tadashi ^a   Muratani, Emiko ^a   Fujii, Katsuhiko ^a  

^a TEIJIN LTD   (Japan)

Author keywords

Human neutrophil elastase; Lung injury; Synthetic elastase inhibitor

Indexed keywords

ELASTASE INHIBITOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LEUKOCYTE ELASTASE; LIPOPOLYSACCHARIDE; PROTEINASE; TEI 8362; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HAMSTER; INHALATIONAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG HEMORRHAGE; LUNG INJURY; MALE; NEUTROPHILIA; NONHUMAN; PRIORITY JOURNAL;

EID: 0033012580     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702425     Document Type: Article

References (27)

1. BARRY, T.P., STEVEN, I., CASSANDRAY, M., LYNN, D.G. & ALLEN, B.C. (1990). A modified bronchoalveolar lavage procedure that allows measurement of lung epithelial lining fluid volume. Am. Rev, Respir. Dis., 141, 314-320.
2. CAI, T.-Q. & WRIGHT, S.D. (1996). Human leukocyte elastase is an endogenous ligand for the integrin CR3 (CD11b/CD18, Mac-1, alpha M beta 2) and modulates polymorphonuclear leukocyte adhesion. J. Exp. Med., 184, 1213-1223.
3. DURHAM, S.L., HARE, C.M., ANGELASTRO, M.R., BURKHART, J.P., KOEHL, J.R., MARQUART, A.L., MEHDI, S., PEET, N.P. & JANUSZ, M.J. (1994). Pharmacology of N-[4-(4-morpholinyl-carbonyl) benzoyl]-L-valyl-N-[3,3,4,4,4-pentafluoro-I-(1-methy-lethyl)-2-oxobutyl]-L- prolinamide (MDL-101, 146): A potent orally active inhibitor of human neutrophil elastase. J. Pharmacol. Exp. Ther., 270, 185-191.
4. FLETCHER, D.S., OSINGA, D.G., HAND, K.M., DELLEA, S.P., ASHE, B.M., MUMFORD, R.A., DAVIES, P., HAGMANN, W., FINKE, P.E., DOHERTY, J.B. & BONNEY, R.J. (1990). A comparison of α-1-proteinase inhibitor methoxysuccinyl-ala-ala-pro-val-chloromethylketone and specific β-lactam inhibitors in an acute model of human polymorphonuclear leukocyte elastase-induced lung haemorrhage in the hamster. Am. Rev. Respir. Dis., 141, 672-677.
5. GOLDSTEIN, W. & DÖRING, G. (1986). Lysosomal enzymes from polymorphonudear leukocytes and proteinase inhibitors in cystic fibrosis. Am. Rev. Respir. Dis., 134, 49-56.
6. HERBERT, J.M., FREHEL, D., ROSSO, M.P., SEBAN, E., CASTET, C., PEPIN, O., MAFFRAND, J.P. & LE FUR, G. (1992). Biochemical and pharmacological activities of SR 26831, a potent and selective elastase inhibitor. J. Pharmacol. Exp. Ther., 260, 809-816.
7. HICKSON, M., ALEXANDER, D.J., SIBLEY, P.R., LIBRETTO, S.E., EZAKI, Y., MASUOKA, M. & TOMON, Y. (1992). Single inhalation toxicity study on fluticasone propionate in rats and dogs. Jpn. Pharmacol. Ther., 20, 1501-1508.
8. KAWABATA, K., SUZUKI, M., SUGITANI, M., IMAKI, K., TODA, M. & MIYAMOTO, T. (1991). ONO-5046, a new inhibitor of human neutrophil elastase. Biochem. Biophys. Res. Commun., 177, 814-820.
9. LUCEY, E.C., STONE, P.J., CICCOLELLA, D.E., BREUER, R., CHRISTENSEN, T.G., THOMPSON, R.C. & SNIDER, G.L. (1990). Recombinant human secretory leukocyte-protease inhibitor: In vitro properties, and amelioration of human neutrophil elastase-induced emphysema and secretory cell metaplasia in the hamster. J. Lab. Clin. Med., 115, 224-232.
10. MARIO, J.C., KIICHIRO, N., MORRIS, Z. & JAMES, C.R. (1979). Sensitive substrates for human leukocyte and pancreatic elastase: A study of the merits of various chromophoric and fluorogenic leaving groups in assay for serine proteases. Anal. Biochem., 99, 53-64.
11. MATSUBARA, T. & SHIBATA, S. (1969). Evaluation of the internationally standardized method for haemoglobinometry. Clin. Chim. Acta, 23, 427-430.
12. MIKAMI, M. (1991). Clinical and pathophysiological significance of neutrophil elastase in sputum and the effect of erythromycin in chronic respiratory disease. Jpn. J. Thora. Dis., 29, 72-83.
13. MITSUHASHI, H., ASANO, S., NONAKA, T., MASUDA, K. & KIYOKI, M. (1997). Potency of truncated secretory leukoprotease inhibitor assessed in acute lung injury models in hamsters. J. Pharmacol. Exp. Ther., 282, 1005-1010.
14. NAKAMURA, H., YOSHIMURA, K., MCELVANEY, N.G. & CRYSTAL, R.G. (1992). Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J. Clin. Invest., 89, 1478-1484.
15. NEUMANN, U., STURZEBECHER, J., LEISTNER, S. & VIEWEG, H. (1991). Inhibition of chymotrypsin and pancreatic elastase by 4H-3, 1-benzoxazin-4-ones. J. Enzyme Inhibition, 4, 227-232.
16. PICCIONI, P.D., KRAMPS, J.A., RUDOLPHUS, A., BULGHERONI, A. & LUISETTI, M. (1992). Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Chest, 102, 1470-1476.
17. SCHUSTER, A., UEKI, I. & NADEL, J.A. (1992). Neutrophil elastase stimulates tracheal submucosal gland secretion that is inhibited by ICI 200, 355. Am. J. Physiol., 262 (lung Cell. Mol. Physiol. 6), L86-L91.
18. SHINGUH, Y., IMAI, K., YAMAZAKI, A., INAMURA, N., SHIMA, I., WAKABAYASHI, A., HIGASHI, Y. & ONO, T. (1997). Biochemical and pharmacological characterization of FK706, a novel elastase inhibitor. Eur. J. Pharmacol., 337, 63-71.
19. STOCKLEY, R.A. (1987). Bronchiectasis-New therapeutic approaches based on pathogenesis. Clinics in Chest Medicine, 8, 481-493.
20. SUZUKI, T., WANG, W., LIN, J.-T., SHIRATO, K., MITSUHASHI, H. & INOUE, H. (1996). Aerosolized human neutrophil elastase induces airway constriction and hyperresponsiveness with protection by intravenous pretreatment with half-length secretory leukoprotease inhibitor. Am. J. Respir. Crit. Care Med., 153, 1405-1411.
21. TABACHNIK, E., SCHUSTER, A., GOLD, W.M. & NADEL, J.A. (1992). Role of neutrophil elastase in allergen-induced lysozyme secretion in the dog trachea. J. Appl. Physiol., 73, 695-700.
22. THOMPSON, K. & RABINOVITCH, M. (1996). Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular matrix-bound basic fibroblast growth factor. J. Cell. Physiol., 166, 495-505.
23. TOSI, M., ZAKEM, H. & BERGER, M. (1990). Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J. Clin. Invest., 86, 300-308.
24. TWUMASI, D.Y. & LEINER, I.E. (1977). Proteases from purulent sputum. Purification and properties of the elastase and chymotrypsin-like enzymes. J. Biol. Chem., 252, 1917-1926.
25. UEJIMA, Y., KOKUBO, M., OSHIDA, J., KAWABATA, H., KATO, Y. & FIJII, K. (1993). 5-methyl-4H-3, 1-benzoxazin-4-one derivative: Specific inhibitor of human leukocyte elastase. J. Pharmacol. Exp. Ther., 265, 516-523.
26. U.S. ENVIRONMENTAL PROTECTION AGENCY. (1982). Air quality criteria for sulfur oxides and particulates. EPA-600/8-82-029c, II-28 - II-32.
27. WILLIAMS, J.C., STEIN, R.L., GILES, R.A. & KRELL, K.O. (1991). Biochemistry and pharmacology for ICI 200,880, a synthetic peptide inhibitor. Ann. N.Y. Acad. Sci., 624, 230-243.